Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension.

Literature DB >> 19015413

Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension.

Stuart Rich¹, Marlene Rabinovitch.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 19015413 DOI： 10.1161/CIRCULATIONAHA.107.723007

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

Keyword Cloud
Cited

× No keyword cloud information.

28 in total

Review 1. An update on the evaluation and management of pulmonary hypertension in scleroderma.

Authors: John G Coghlan; Benjamin Schreiber; Benjamin Schrieber
Journal: Curr Rheumatol Rep Date: 2012-02 Impact factor: 4.592

Review 2. Pulmonary hypertension with left-sided heart disease.

Authors: Marco Guazzi; Ross Arena
Journal: Nat Rev Cardiol Date: 2010-10-05 Impact factor: 32.419

Review 3. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice.

Authors: Natalia C Berry; Agarwal Manyoo; William M Oldham; Thomas E Stephens; Ronald H Goldstein; Aaron B Waxman; Julie A Tracy; Peter J Leary; Jane A Leopold; Scott Kinlay; Alexander R Opotowsky; David M Systrom; Bradley A Maron
Journal: Pulm Circ Date: 2015-12 Impact factor: 3.017

4. Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance.

Authors: Erik H Van Iterson; Eric M Snyder; Michael J Joyner; Bruce D Johnson; Thomas P Olson
Journal: Int J Cardiol Date: 2015-08-14 Impact factor: 4.164

5. Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.

Authors: Jing Tian; Sohrab Fratz; Yali Hou; Qing Lu; Agnes Görlach; John Hess; Christian Schreiber; Sanjeev A Datar; Peter Oishi; John Nechtman; Robert Podolsky; Jin-Xiong She; Jeffrey R Fineman; Stephen M Black
Journal: Physiol Genomics Date: 2010-10-26 Impact factor: 3.107

6. Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.

Authors: Julien Magne; Dania Mohty; Alessandro Piccardo; Cyrille Boulogne; Mathieu Deltreuil; Vincent Petitalot; Najmeddine Echahidi; Nicole Darodes; Patrice Virot; Thibaud Damy; Victor Aboyans
Journal: Clin Res Cardiol Date: 2017-02-14 Impact factor: 5.460

Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension.

Review 1. An update on the evaluation and management of pulmonary hypertension in scleroderma.

Review 2. Pulmonary hypertension with left-sided heart disease.

Review 3. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice.

4. Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance.

5. Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.

6. Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.

Review 7. Heart failure and pulmonary hypertension.

Review 8. Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Review 9. Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).

10. Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.